Bayer AG reports a 3.6% decline in Q2 sales to €10.7 billion, with net losses widening to €199 million. The first half of 2025 sees a 1.7% sales drop and a 44% decrease in net inco...
Bayer AG's stock fell over 5% after reporting a 3.6% sales decline and cutting 12,179 jobs since 2023. Investors are also wary of impending US pharmaceutical tariffs.
Bayer AG's shares surged over 11% after reporting Q1 2025 earnings that exceeded expectations, with revenues at €13.7 billion. CEO Bill Anderson reaffirmed the 2025 outlook, showca...
Bayer AG reports stable Q1 sales of €13.7 billion for fiscal 2025, with a significant drop in net income. The company reaffirms its 2025 guidance, highlighting growth in the Pharma...
Bayer AG will close its Frankfurt crop protection operations by 2028 due to Asian market pressures, regulatory challenges, and trade barriers. The company plans to relocate or inte...
Bayer AG's stock rose 4.7% after announcing Q4 2024 earnings exceeding expectations, with €1.9 billion EBITDA and €11.7 billion sales. Despite a tough 2025 forecast, the company an...
Bayer AG reports a 1% decrease in Q4 sales to €11.7 billion and a 2.2% drop in full-year sales to €46.6 billion. Despite challenges, the company sees a quarterly net income improve...
